EGFR‐ERK pathway regulates CSN6 to contribute to PD‐L1 expression in glioblastoma
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
EGFR‐ERK pathway regulates CSN6 to contribute to PD‐L1 expression in glioblastoma
Authors
Keywords
-
Journal
MOLECULAR CARCINOGENESIS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2020-03-05
DOI
10.1002/mc.23176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IDO1 Expression Is Associated With Immune Tolerance and Poor Prognosis in Patients With Surgically Resected Esophageal Cancer
- (2018) Yuki Kiyozumi et al. ANNALS OF SURGERY
- Eradication of Triple-Negative Breast Cancer Cells by Targeting Glycosylated PD-L1
- (2018) Chia-Wei Li et al. CANCER CELL
- Immune checkpoint therapy in liver cancer
- (2018) Feng Xu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The IDH1 Mutation-Induced Oncometabolite, 2-Hydroxyglutarate, May Affect DNA Methylation and Expression of PD-L1 in Gliomas
- (2018) Luyan Mu et al. Frontiers in Molecular Neuroscience
- Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
- (2018) Yiting Wang et al. Frontiers in Pharmacology
- Regulatory mechanisms of PD-L1 expression in cancer cells
- (2018) Yongyu Shi CANCER IMMUNOLOGY IMMUNOTHERAPY
- Epidermal growth factor induces STAT1 expression to exacerbate the IFNr-mediated PD-L1 axis in epidermal growth factor receptor-positive cancers
- (2018) Chun-Chia Cheng et al. MOLECULAR CARCINOGENESIS
- Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer
- (2018) Chih-Yang Huang et al. Scientific Reports
- Nobel committee honors tumor immunologists
- (2018) Anand Rotte et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer immunologists scoop medicine Nobel prize
- (2018) Heidi Ledford et al. NATURE
- Oncogenic RAS Signaling Promotes Tumor Immunoresistance by Stabilizing PD-L1 mRNA
- (2017) Matthew A. Coelho et al. IMMUNITY
- Assessment of PD-1 positive cells on initial and secondary resected tumor specimens of newly diagnosed glioblastoma and its implications on patient outcome
- (2017) Tsubasa Miyazaki et al. JOURNAL OF NEURO-ONCOLOGY
- Immunochemotherapy benefits in gastric cancer patients stratified by programmed death-1 ligand-1
- (2017) Jun-Te Hsu et al. JOURNAL OF SURGICAL RESEARCH
- Cost-effectiveness of IDH testing in diffuse gliomas according to the 2016 WHO classification of tumors of the central nervous system recommendations
- (2017) John C DeWitt et al. NEURO-ONCOLOGY
- BIN1 reverses PD-L1-mediated immune escape by inactivating the c-MYC and EGFR/MAPK signaling pathways in non-small cell lung cancer
- (2017) J Wang et al. ONCOGENE
- Comprehensive analysis of PD-L1 expression in glioblastoma multiforme
- (2017) Dieter Henrik Heiland et al. Oncotarget
- A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
- (2017) Ti Wen et al. Cancer Immunology Research
- Immune classifications with cytotoxic CD8+ and Th17 infiltrates are predictors of clinical prognosis in glioblastoma
- (2017) Rachid Madkouri et al. OncoImmunology
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Deubiquitination and Stabilization of PD-L1 by CSN5
- (2016) Seung-Oe Lim et al. CANCER CELL
- Postarrest stalling rather than crawling favors CD8+ over CD4+ T-cell migration across the blood-brain barrier under flow in vitro
- (2016) Henriette Rudolph et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Erratum: Corrigendum: Structural and functional features of central nervous system lymphatic vessels
- (2016) Antoine Louveau et al. NATURE
- CSN6 controls the proliferation and metastasis of glioblastoma by CHIP-mediated degradation of EGFR
- (2016) J Hou et al. ONCOGENE
- ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development
- (2015) Lekun Fang et al. CANCER CELL
- Nivolumab and pembrolizumab as immune-modulating monoclonal antibodies targeting the PD-1 receptor to treat melanoma
- (2015) Elnaz Faghfuri et al. Expert Review of Anticancer Therapy
- Low expression of Bin1, along with high expression of IDO in tumor tissue and draining lymph nodes, are predictors of poor prognosis for esophageal squamous cell cancer patients
- (2015) Yunlong Jia et al. INTERNATIONAL JOURNAL OF CANCER
- Structural and functional features of central nervous system lymphatic vessels
- (2015) Antoine Louveau et al. NATURE
- Immune checkpoint blockade therapy: The 2014 Tang prize in biopharmaceutical science
- (2015) Chia-Rui Shen et al. Biomedical Journal
- Immunotherapy for Primary Brain Tumors: No Longer a Matter of Privilege
- (2014) P. E. Fecci et al. CLINICAL CANCER RESEARCH
- Crystal structure of the human COP9 signalosome
- (2014) Gondichatnahalli M. Lingaraju et al. NATURE
- Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
- (2014) Anna Sophie Berghoff et al. NEURO-ONCOLOGY
- B7-H3 and B7-H1 expression in cerebral spinal fluid and tumor tissue correlates with the malignancy grade of glioma patients
- (2014) APARAJITA BARAL et al. Oncology Letters
- CSN6 drives carcinogenesis by positively regulating Myc stability
- (2014) Jian Chen et al. Nature Communications
- PD1 (CD279) and PD-L1 (CD274, B7H1) expression in primary central nervous system lymphomas (PCNSL)
- (2013) Anna Sophie Berghoff et al. CLINICAL NEUROPATHOLOGY
- PTEN Loss Increases PD-L1 Protein Expression and Affects the Correlation between PD-L1 Expression and Clinical Parameters in Colorectal Cancer
- (2013) Minmin Song et al. PLoS One
- HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53
- (2012) Yuwen Xue et al. CELL CYCLE
- CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2005-2009
- (2012) T. A. Dolecek et al. NEURO-ONCOLOGY
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulation of Cullin RING Ligases
- (2007) Sara K. Hotton et al. Annual Review of Plant Biology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started